Clinical Trials Directory

Trials / Conditions / Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive

Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive

3 registered clinical trials studyying Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingAnti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Re
NCT07166419
Ohio State University Comprehensive Cancer CenterPhase 1
RecruitingHA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After
NCT03326921
Fred Hutchinson Cancer CenterPhase 1
TerminatedPhase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies
NCT02381548
National Cancer Institute (NCI)Phase 1